SynthesisCardiovascular diabetology2021

SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs.

Dario Giugliano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.